Cardiovascular effects of melatonin receptor agonists

Melatonin and cardioprotection in the acute myocardial infarction: A promising cardioprotective agent

(2012) Alberto Dominguez-Rodriguez et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Melatonina y enfermedad cardiovascular: ¿mito o realidad?

(2012) Alberto Dominguez-Rodriguez et al.   REVISTA ESPANOLA DE CARDIOLOGIA

A Benefit-Risk Assessment of Agomelatine in the Treatment of Major Depression

(2011) Robert H. Howland   DRUG SAFETY

Tasimelteon for insomnia

(2011) D Alan Lankford   EXPERT OPINION ON INVESTIGATIONAL DRUGS

Agomelatine for the treatment of major depressive disorder

(2011) Regina M Carney et al.   EXPERT OPINION ON PHARMACOTHERAPY

Efficacy and tolerability of ramelteon in a double-blind, placebo-controlled, crossover study in Japanese patients with chronic primary insomnia

(2011) Masako Kohsaka et al.   Expert Review of Neurotherapeutics

Are melatonin and its receptor agonist specific antihypertensive modulators of resistant hypertension caused by disrupted circadian rhythm?

(2011) Kazuomi Kario   Journal of the American Society of Hypertension

Melatonin and the Metabolic Syndrome: Physiopathologic and Therapeutical Implications

(2011) Daniel P. Cardinali et al.   NEUROENDOCRINOLOGY

A review of ramelteon in the treatment of sleep disorders

(2011) David Neubauer   Neuropsychiatric Disease and Treatment

Antidepressant- and anxiolytic effects of the novel melatonin agonist Neu-P11 in rodent models

(2010) Shao-wen Tian et al.   ACTA PHARMACOLOGICA SINICA

Usefulness of Intraplatelet Melatonin Levels to Predict Angiographic No-Reflow After Primary Percutaneous Coronary Intervention in Patients With ST-Segment Elevation Myocardial Infarction

(2010) Alberto Dominguez-Rodriguez et al.   AMERICAN JOURNAL OF CARDIOLOGY

Ramelteon attenuates age-associated hypertension and weight gain in spontaneously hypertensive rats

(2010) Gregory F. Oxenkrug et al.   Annals of the New York Academy of Sciences

Nightly treatment of primary insomnia with prolonged release melatonin for 6 months: a randomized placebo controlled trial on age and endogenous melatonin as predictors of efficacy and safety

(2010) Alan G Wade et al.   BMC Medicine

Melatonin Receptor Agonists: New Options for Insomnia and Depression Treatment

(2010) Gilberto Spadoni et al.   CNS Neuroscience & Therapeutics

Prolonged release melatonin in the treatment of primary insomnia: evaluation of the age cut-off for short- and long-term response

(2010) Alan G. Wade et al.   CURRENT MEDICAL RESEARCH AND OPINION

Investigational melatonin receptor agonists

(2010) Rüdiger Hardeland   EXPERT OPINION ON INVESTIGATIONAL DRUGS

Urinary melatonin and risk of incident hypertension among young women

(2010) John P Forman et al.   JOURNAL OF HYPERTENSION

Melatonin improves the restoration of endothelium-derived constricting factor signalling and inner diameter in the rat femoral artery after cessation of L-NAME treatment

(2010) Ludovit Paulis et al.   JOURNAL OF HYPERTENSION

Continuous light and L-NAME-induced left ventricular remodelling: different protection with melatonin and captopril

(2010) Fedor Simko et al.   JOURNAL OF HYPERTENSION

MT2 Receptors Mediate the Inhibitory Effects of Melatonin on Nitric Oxide-Induced Relaxation of Porcine Isolated Coronary Arteries

(2010) R. R. Tunstall et al.   JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS

Melatonin prevents hypertension and increased asymmetric dimethylarginine in young spontaneous hypertensive rats

(2010) You-Lin Tain et al.   JOURNAL OF PINEAL RESEARCH

Melatonin treatment improves blood pressure, lipid profile, and parameters of oxidative stress in patients with metabolic syndrome

(2010) Marzena Koziróg et al.   JOURNAL OF PINEAL RESEARCH

New approaches in the management of insomnia: weighing the advantages of prolonged-release melatonin and synthetic melatoninergic agonists

(2010) Ruediger Hardeland   Neuropsychiatric Disease and Treatment

Ramelteon: a review of its therapeutic potential in sleep disorders

(2009) Seithikurippu R. Pandi-Perumal et al.   ADVANCES IN THERAPY

Melatonin: Signaling mechanisms of a pleiotropic agent

(2009) Rüdiger Hardeland   BIOFACTORS

Assessment of the effects of physiological release of melatonin on arterial distensibility and blood pressure

(2009) Mustafa Yildiz et al.   CARDIOLOGY IN THE YOUNG

Agomelatine, a melatonin agonist with antidepressant properties

(2009) Steven L Dubovsky et al.   EXPERT OPINION ON INVESTIGATIONAL DRUGS

Effect of L-NAME-induced hypertension on melatonin receptors and melatonin levels in the pineal gland and the peripheral organs of rats

(2009) Miroslava Benova et al.   HYPERTENSION RESEARCH

Melatonin for nondippers with coronary artery disease: assessment of blood pressure profile and heart rate variability

(2009) Tomasz Rechciński et al.   HYPERTENSION RESEARCH

Melatonin and Melatonergic Drugs on Sleep: Possible Mechanisms of Action

(2009) Venkataramanujan Srinivasan et al.   INTERNATIONAL JOURNAL OF NEUROSCIENCE

Melatonin prevents fibrosis but not hypertrophy development in the left ventricle of NG-nitro-L-arginine-methyl ester hypertensive rats

(2009) Ludovit Paulis et al.   JOURNAL OF HYPERTENSION

Effect of melatonin, captopril, spironolactone and simvastatin on blood pressure and left ventricular remodelling in spontaneously hypertensive rats

(2009) Fedor Simko et al.   JOURNAL OF HYPERTENSION

Melatonin interactions with blood pressure and vascular function during l-NAME-induced hypertension

(2009) Ludovit Paulis et al.   JOURNAL OF PINEAL RESEARCH

NEU-P11, a novel melatonin agonist, inhibits weight gain and improves insulin sensitivity in high-fat/high-sucrose-fed rats

(2009) Meihua She et al.   PHARMACOLOGICAL RESEARCH

Effects of circadian disruption on the cardiometabolic system

(2009) Melanie Rüger et al.   REVIEWS IN ENDOCRINE & METABOLIC DISORDERS

Beyond the monoaminergic hypothesis: Agomelatine, a new antidepressant with an innovative mechanism of action

(2009) Siegfried Kasper et al.   WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY

The Role of Melatonin in the Pathogenesis of Hypertension in Rats With Metabolic Syndrome

(2008) A. Leibowitz et al.   AMERICAN JOURNAL OF HYPERTENSION

Agomelatine Treatment of Major Depressive Disorder

(2008) Christian R Dolder et al.   ANNALS OF PHARMACOTHERAPY

Melatonin, hormone of darkness and more – occurrence, control mechanisms, actions and bioactive metabolites

(2008) R. Hardeland   CELLULAR AND MOLECULAR LIFE SCIENCES

EFFECTS OF MELATONIN ON BLOOD PRESSURE IN STRESS-INDUCED HYPERTENSION IN RATS

(2008) Chun-Mei Xia et al.   CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY

MELATONIN REDUCES BLOOD PRESSURE IN RATS WITH STRESS-INDUCED HYPERTENSION VIA GABAARECEPTORS

(2008) Hua-Li Li et al.   CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY

Melatonin Receptor Agonists: SAR and Applications to the Treatment of Sleep-Wake Disorders

(2008) Silvia Rivara et al.   CURRENT TOPICS IN MEDICINAL CHEMISTRY

Sleep dysfunction in heart failure

(2008) Shahrokh Javaheri   Current Treatment Options in Neurology

Melatonin agonist tasimelteon (VEC-162) for transient insomnia after sleep-time shift: two randomised controlled multicentre trials

(2008) Shantha MW Rajaratnam et al.   LANCET

Association of ischemia-modified albumin and melatonin in patients with ST-elevation myocardial infarction

(2007) Alberto Dominguez-Rodriguez et al.   ATHEROSCLEROSIS

Dose translation from animal to human studies revisited

(2007) Shannon Reagan-Shaw et al.   FASEB JOURNAL